Inclusion Criteria:  Patients with a diagnosis of aRCC. Patients aged ≥18 years at aRCC diagnosis treated with a 1L IO containing combination therapy who have progressed to a 2L treatment.  Exclusion Criteria:  Patient's hospital medical records are unavailable for review; Patients have started a 2L treatment as part of a Renal Carcinoma Treatment (RCT).